A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety, tolerability and preliminary efficacy of
SD-809 in the treatment of motor and phonic tics of Tourette Syndrome and to evaluate the
pharmacokinetic of SD-809 and its metabolites.